[基于决策树算法构建多发性骨髓瘤患者在博尔特佐米布治疗后预后风险预测模型]
Tao Jiang1, Yuan Luo2, Huan Wang1
1Department of Hematology, The People's Hospital of Jianyang City, Jianyang 641400, Sichuan Province, China.
Zhongguo shi yan xue ye xue za zhi
|November 14, 2025
概括
这项研究开发了一种决策树模型,用于预测多发性骨髓瘤 (MM) 预后,在接受博雷佐米布治疗后. 该模型有效地识别高风险因素,帮助临床医生制定预防策略,以获得更好的患者结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 医疗信息学 医疗信息学
背景情况:
- 多发性骨髓瘤 (MM) 是一种血液性恶性瘤.
- 博尔特佐米布是MM的关键治疗方法.
- 预测预后对于管理MM患者至关重要.
研究的目的:
- 为了确定影响MM预后产后预后的因素.
- 为MM预后开发决策树风险预测模型.
主要方法:
- 分析了170名接受博特佐米布治疗的MM患者.
- 用临床数据来确定预后因素.
- 使用SPSS Modeler构建了一个决策树模型.
主要成果:
- 卡帕轻链水平,PLT,Hcy,Scr,LDH,SF和β2-MG是预后不佳的独立风险因素.
- 与后勤回归 (AUC=0.881) 相比,决策树模型显示出优异的预测性能 (AUC=0.895).
- 卡帕轻链水平成为决策树模型中最重要的预测因素.
结论:
- 决策树模型为预测博雷佐米布治疗后的MM预后提供了高价值.
- 该模型有助于识别针对性预防干预的高风险因素.
- 这为管理MM患者的临床医生提供了一个实用的工具.
更多相关视频
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.6K
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
633
相关概念视频
Survival Tree
375
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
Building a Survival Tree
Constructing a...
Building a Survival Tree
Constructing a...
375
Cancer Survival Analysis
634
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
634
